These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26395136)

  • 21. Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop.
    Stacey G; Andrews P; Asante C; Barbaric I; Barry J; Bisset L; Braybrook J; Buckle R; Chandra A; Coffey P; Crouch S; Driver P; Evans A; Gardner J; Ginty P; Goldring C; Hay DC; Healy L; Hows A; Hutchinson C; Jesson H; Kalber T; Kimber S; Leathers R; Moyle S; Murray T; Neale M; Pan D; Park BK; Rebolledo RE; Rees I; Rivolta MN; Ritchie A; Roos EJ; Saeb-Parsy K; Schröder B; Sebastian S; Thomas A; Thomas RJ; Turner M; Vallier L; Vitillo L; Webster A; Williams D
    Regen Med; 2018 Dec; 13(8):935-944. PubMed ID: 30488776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
    Duelen R; Sampaolesi M
    EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecules for cell reprogramming and heart repair: progress and perspective.
    Xie M; Cao N; Ding S
    ACS Chem Biol; 2014 Jan; 9(1):34-44. PubMed ID: 24372513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier.
    Papapetrou EP
    Adv Exp Med Biol; 2017; 1013():219-240. PubMed ID: 29127683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-based therapy approaches: the hope for incurable diseases.
    Buzhor E; Leshansky L; Blumenthal J; Barash H; Warshawsky D; Mazor Y; Shtrichman R
    Regen Med; 2014; 9(5):649-72. PubMed ID: 25372080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Organoids: Tools for Understanding Biology and Treating Diseases.
    Schutgens F; Clevers H
    Annu Rev Pathol; 2020 Jan; 15():211-234. PubMed ID: 31550983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Developments in Cardiac Regeneration.
    Le TY; Thavapalachandran S; Kizana E; Chong JJ
    Heart Lung Circ; 2017 Apr; 26(4):316-322. PubMed ID: 27916592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pluripotent stem cells in regenerative medicine: challenges and recent progress.
    Tabar V; Studer L
    Nat Rev Genet; 2014 Feb; 15(2):82-92. PubMed ID: 24434846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.
    Xu XQ; Sun W
    J Cell Biochem; 2013 Jan; 114(1):39-46. PubMed ID: 22903726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cells and their potential clinical applications in psychiatric disorders.
    Ratajczak MZ; Ciechanowicz AK; Kucharska-Mazur J; Samochowiec J
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt A):3-9. PubMed ID: 28435007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.
    Whiting P; Kerby J; Coffey P; da Cruz L; McKernan R
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140375. PubMed ID: 26416684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.
    Kimbrel EA; Lanza R
    Regen Med; 2015; 10(2):99-102. PubMed ID: 25835474
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating β-cells in vitro: progress towards a Holy Grail.
    Fryer BH; Rezania A; Zimmerman MC
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):112-7. PubMed ID: 23426161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.